Alpha Tau Medical Ltd. (DRTSW)
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.
$2.62-0.03%
StockGlow Score
Neutral
BearishBullish
1 year ago+156.9%
The outlook
Alpha Tau Medical Ltd. currently reads as neutral based on 48% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
52-week range48% of the way from its 52-week low to high
Market cap
—
52-wk high
$2.80
52-wk low
$2.46
50-day avg
—
200-day avg
—
Trailing P/E
—